Author:
Knight Dacre R. T.,Confiado Sunnie M.,Bruno Katelyn A.,Fairweather DeLisa,Seymour-Sonnier Andrea M.,Jain Angita,Gehin Jessica M.,Whelan Emily R.,Culberson Joshua H.,Munipalli Bala,Dawson Nancy L.,Rozen Todd D.,Wick Joseph J.,Kotha Archana
Abstract
AbstractIn a large academic medical center, patient requests from the community and internal referrals for evaluation of suspected hypermobility conditions were being denied consultation because services specific to this condition were not available. We identified this gap and developed a comprehensive evaluation for this unique patient population. The objective of this paper is to demonstrate a solution for improving outcomes in a neglected patient population by establishing an innovative outpatient clinic specifically tailored for patients with EDS.We describe the lessons learned on establishing a specialty clinic for treating patients with hypermobility syndromes including hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobile syndrome disorder (HSD). Findings were collected from a patient focus group that was instrumental in understanding common care gaps. We document the firsthand perspective of three patients presenting with hypermobility accompanied by joint pain and denote the complicated state of healthcare in recognizing and treating this condition. A summary of patient demographics and characteristics was collected from patients seen in the clinic from November 14, 2019 to April 13, 2021.The firsthand accounts illustrate the challenges faced in treating this condition and the need for, and success of, this clinic using a coordinated care model. Demographics reveal a primarily white female population under the age of 50 with many comorbidities. Genetic testing was largely negative, with more patients diagnosed with HSD than hEDS.Our shared experience of launching a successful EDS clinic may assist other clinicians in establishing similar care models.
Funder
Mayo Clinic
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Blackburn PR, Xu Z, Tumelty KE, Zhao RW, Monis WJ, Harris KG, et al. Bi-allelic alterations in AEBP1 lead to defective collagen assembly and connective tissue structure resulting in a variant of Ehlers-Danlos syndrome. Am J Hum Genet. 2018;102(4):696–705. https://doi.org/10.1016/j.ajhg.2018.02.018.
2. Malfait F, Castori M, Francomano CA, Giunta C, Kosho T, Byers PH. The Ehlers-Danlos syndromes. Nat Rev Dis Primers. 2020;6(1):64. https://doi.org/10.1038/s41572-020-0194-9.
3. Miller E, Grosel JM. A review of Ehlers-Danlos syndrome. JAAPA. 2020;33(4):23–8. https://doi.org/10.1097/01.JAA.0000657160.48246.91.
4. Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, et al. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type) clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017;175(1):48–69.
5. Hamonet C, Schatz PM, Bezire P, Ducret L, Brissot R. Cognitive and psychopathological aspects of Ehlers-Danlos syndrome - experience in a specialized medical consultation. Research Advances in Brain Disorders and Therapy. 2018:RABDT-104. doi: 10.29011/ RABDT-104.100004.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献